Our Research

Learn more

Treatment

in South Africa

Learn more

BRIGHT Academy

BRIGHT Academy is an umbrella organisation for 8 research and health institutions that have focused on Female Genital Schistosomiasis (FGS) since the 1990ā€™s, its researchers are at the forefront of FGS research. They were the first to show an association between FGS and HIV, did the first community-based study on fertility and FGS, showed that children have FGS, and found an association between HPV and FGS. Currently the focus of BRIGHT Academy is on transfer of knowledge to health professionals and management of... read more

Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa

Mahala Livingston, Pavitra Pillay, Siphosenkosi Gift Zulu, Leiv Sandvik, Jane Dene Kvalsvig, Silindile Gagai, Hashini Nilushika Galappaththi-Arachchige, Elisabeth Kleppa, Patricia Ndhlovu, Birgitte Vennervald, Svein Gunnar Gundersen, Myra Taylor, Eyrun F Kjetland

Link

Women with female genital schistosomiasis (FGS, Bilharzia) have been found to have genital symptoms and a 3-fold higher risk of HIV infection. In South Africa, in KwaZulu-Natal rural schools, this study indicates that Bilharzia treatment could prevent genital symptoms in more than 200,000 young women. Furthermore, it is feasible that more than 5,000 HIV infections could be prevented in adolescent girls and young women by treatment and prevention of Bilharzia.

New York Times

Institutions